ST Pharm, 3Q Sales of 60.8 Billion KRW... Operating Profit of 4.5 Billion KRW
[Asia Economy Reporter Chunhee Lee] ST Pharm announced on the 31st that its provisional operating results for the third quarter of this year were sales of 60.825 billion KRW, operating profit of 4.542 billion KRW, and net profit of 9.923 billion KRW. Sales grew by 31.4% compared to the same period last year, but operating profit decreased by 41.6%. Net profit increased by 28.2%.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
For the cumulative total this year, sales reached 148.927 billion KRW, achieving a 30.7% growth compared to last year. Cumulative operating profit was 8.613 billion KRW, and net profit was 15.453 billion KRW, growing by 40.2% and 85.3%, respectively.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
